About Chongqing Denali Pharmaceutical Technology
Chongqing Denali Pharmaceutical Technology is a company based in Chongqing (China) founded in 2017 by Min Meng and Laixin Wang was acquired by Resolian in November 2023.. Chongqing Denali Pharmaceutical Technology operates in a competitive market with competitors including Crescendo Health, Advance Research Associates, Allianz Biosciences, LeaderMed Group and Renew BioTechnologies, among others.
- Headquarter Chongqing, China
- Founders Min Meng, Laixin Wang
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chongqing Denali Pharmaceutical Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chongqing Denali Pharmaceutical Technology
Chongqing Denali Pharmaceutical Technology has secured backing from 1 investor. Prominent investors backing the company include Resolian. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biologics drug development and bioanalytic services are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chongqing Denali Pharmaceutical Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Chongqing Denali Pharmaceutical Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chongqing Denali Pharmaceutical Technology Comparisons
Competitors of Chongqing Denali Pharmaceutical Technology
Chongqing Denali Pharmaceutical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Crescendo Health, Advance Research Associates, Allianz Biosciences, LeaderMed Group and Renew BioTechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Platform enabling clinical study participants to assemble and contribute health data
|
|
| domain | founded_year | HQ Location |
Biostatistics and data management services are provided by the CRO.
|
|
| domain | founded_year | HQ Location |
Provides probiotic contract manufacturing, packaging, and research services.
|
|
| domain | founded_year | HQ Location |
Provides pharmaceutical platform for drug development, testing, approval, and distribution.
|
|
| domain | founded_year | HQ Location |
Develops genomic and epigenomic tools for clinical diagnostics, bridging research to healthcare applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chongqing Denali Pharmaceutical Technology
Frequently Asked Questions about Chongqing Denali Pharmaceutical Technology
When was Chongqing Denali Pharmaceutical Technology founded?
Chongqing Denali Pharmaceutical Technology was founded in 2017.
Where is Chongqing Denali Pharmaceutical Technology located?
Chongqing Denali Pharmaceutical Technology is headquartered in Chongqing, China.
Who is the current CEO of Chongqing Denali Pharmaceutical Technology?
Min Meng is the current CEO of Chongqing Denali Pharmaceutical Technology. They have also founded this company.
What does Chongqing Denali Pharmaceutical Technology do?
Chongqing Denali Pharmaceutical Technology was established in 2017 in Chongqing, China, as a bioanalytical contract research organization. Laboratory operations are focused on bioanalysis, with services encompassing method development, validation, and sample analysis. Advanced equipment and technology are employed to support pharmaceutical research and development needs across various therapeutic areas. The company operates primarily in the biotechnology sector, serving clients in drug discovery and clinical trials.
Who are the top competitors of Chongqing Denali Pharmaceutical Technology?
Chongqing Denali Pharmaceutical Technology's top competitors include Crescendo Health, Advance Research Associates and VaxTrials.
Who are Chongqing Denali Pharmaceutical Technology's investors?
Chongqing Denali Pharmaceutical Technology has 1 investor. Key investors include Resolian.